PTAB Agrees to Review Novartis’ Patent for an Ophthalmic Injection Syringe – JD Supra

On October 26, 2021, the Patent Trial and Appeal Board (PTAB) granted Regeneron’s petition to institute an inter partes review (IPR) of Novartis’s …